2026-03-09 12:00:23 pm | Source: Religare Broking Ltd
Stock of the day : Aurobindo Pharma Ltd by Target Rs. 1310- Religare Broking Ltd
Aurobindo Pharma Ltd
* AUROPHARMA is demonstrating an improving price structure, characterized by the formation of higher lows and a gradual recovery following the recent corrective phase.
* The stock has moved above the short-term moving average, which is now attempting to cross above the medium-term averages, indicating a potential bullish alignment.
* Recent price action, supported by rising volumes, reflects strengthening buying interest and demand at lower levels.
* Traders may consider initiating long positions within the defined accumulation zone.
Buy Aurobindo Pharma Ltd CMP 1231.90 Range 1228-1232 SL 1190 Target 1310
Please refer disclaimer at https://www.religareonline.com/disclaimer
SEBI Registration number is INZ00017433
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Sector Seasonality Report 09th March 2026 - Axis Sec...
Quote on The sharp sell-off in Indian equities refle...
Government buys back G-Secs worth Rs 6,309 crore in ...
JM Financial Services Hosts Data Centre Day ? an exc...
Weekly Technical Outlook and Picks : Karnataka Bank ...
Honeywell and IIT Bombay Establish Centre of Excelle...
Entrust Family Office Marks 13 Years, Expands NRI Se...
Indian rupee weakens against dollar amid intensified...
Shree Cement Limited Appoints Rachana Sharma as Head...
Weekly Technical Outlook and Picks by Axis Securitie...
